# ğŸ§¬ TrialMatch AI

**AI-Powered Clinical Trial Matching Platform for NSCLC Patients**

[![Streamlit App](https://static.streamlit.io/badges/streamlit_badge_black_white.svg)](https://your-app-url.streamlit.app/)

ğŸ¯ Problem Statement

Despite clinical trials offering access to cutting-edge treatments, only 2â€“5% of adult cancer patients participate in them.
Several systemic barriers drive this underutilization:

Manual, time-consuming trial matching workflows

Complex and inconsistent eligibility criteria

Lack of standardized patient-trial pairing tools

Limited awareness among both clinicians and patients

 ğŸ” _Source:_ [ASCO Educational Book, 2020](https://ascopubs.org/doi/full/10.1200/EDBK_156686)

ğŸ” _Source:_ [PMC Systematic Review: Enrollment Rates in Cancer Trials](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410951/)


ğŸŒ Market Opportunity

**Market Size:** The global Clinical Trial Management System (CTMS) market is valued at **USD 2.02 billion in 2024**, projected to reach **USD 6.60 billion by 2034**, with a **CAGR of 12.57%** from 2025 to 2034.

ğŸ’¡ _Source:_ [Precedence Research, 2024 â€“ Clinical Trial Management System Market](https://www.precedenceresearch.com/clinical-trial-management-system-market)

## ğŸ’¡ Solution

TrialMatch AI automates patient-trial matching using AI + rules, reducing hours of work to seconds.

### ğŸ”‘ Key Features

ğŸ” **Smart Matching Engine**  
ğŸ¤– **AI-Powered PDF Processing**  
ğŸ‘¥ **Multi-User Collaboration**  
ğŸ“Š **Analytics & Insights**

## ğŸš€ Live Demo

**[ğŸ‘‰ Try TrialMatch AI](https://your-app-url.streamlit.app/)**

![Dashboard](assets/screenshots/main-dashboard.png)

## ğŸ—ï¸ Technical Architecture


